Drug mammoth Pfizer is poised to acquire Botox maker Allergan Plc for more than $150 billion, says Reuters. It is a deal that will create the world’s biggest drug maker, according to people familiar with the matter. And it follows the pattern of the expansive Pfizer to buy seemingly every viable drug firm around. Last year Pfizer gave up on a plan to buy the huge British firm Astrazenca when it was told it would not be permitted to elude U.S taxes by doing so.
